Privacy Policy
This privacy policy will explain how AMR.Solutions uses the personal data we collect from you when you use our website.
Topics:
- What data do we collect?
- How do we collect your data?
- How will we use your data?
- How do we store your data?
- Marketing
- What are your data protection rights?
- What are cookies?
- How do we use cookies?
- What types of cookies do we use?
- How to manage your cookies
- Privacy policies of other websites
- Changes to our privacy policy
- How to contact us
What data do we collect?
AMR.Solutions collects the following data:
- Personal identification information: Name and email address
How do we collect your data?
You directly provide AMR.Solutions with most of the data we collect. We collect data and process data when you:
- Signup for our newsletter
- Voluntarily complete a survey we send to you.
- Use or view our website via your browser’s cookies.
AMR.Solutions may also receive your data indirectly from the following sources:
- Mailchimp, the vendor who delivers our newsletter to you
How will we use your data?
AMR.Solutions collects your data so that we can:
- Manage your newsletter subscription.
We do not share your name or email address with third parties.
How do we store your data?
AMR.Solutions securely stores your data at the data center(s) hosted by Mailchimp. You can read about their privacy policy and their data security practices.
AMR.Solutions will keep your name and email address until you tell us to delete it. You can delete your name and email address by contacting us at privacy@amr.solutions.
Marketing
We do not send you marketing materials.
What are your data protection rights?
AMR.Solutions would like to make sure you are fully aware of all of your data protection rights. Every user is entitled to the following:
The right to access – You have the right to request AMR.Solutions for copies of your personal data. We may charge you a small fee for this service.
The right to rectification – You have the right to request that AMR.Solutions correct any information you believe is inaccurate. You also have the right to request AMR.Solutions to complete the information you believe is incomplete.
The right to erasure – You have the right to request that AMR.Solutions erase your personal data, under certain conditions.
The right to restrict processing – You have the right to request that AMR.Solutions restrict the processing of your personal data, under certain conditions.
The right to object to processing – You have the right to object to AMR.Solutions’s processing of your personal data, under certain conditions.
The right to data portability – You have the right to request that AMR.Solutions transfer the data that we have collected to another organization, or directly to you, under certain conditions.
If you make a request, we have one month to respond to you. If you would like to exercise any of these rights, please contact us at our email at privacy@amr.solutions.
Cookies
Cookies are text files placed on your computer to collect standard Internet log information and visitor behavior information. When you visit our websites, we may collect information from you automatically through cookies or similar technology
For further information, visit https://allaboutcookies.org/.
How do we use cookies?
AMR.Solutions uses cookies in a range of ways to improve your experience on our website, including:
- Understanding how you use our website
- Understanding your location at the country or regional level.
What types of cookies do we use?
There are a number of different types of cookies, however, our website uses:
- Functionality – AMR.Solutions uses these cookies so that we recognize you on our website and remember your previously selected preferences. These could include what language you prefer and location you are in. A mix of first-party and third-party cookies are used.
How to manage cookies
You can set your browser not to accept cookies, and the above website tells you how to remove cookies from your browser. However, in a few cases, some of our website features may not function as a result.
Privacy policies of other websites
The AMR.Solutions website contains links to other websites. Our privacy policy applies only to our website, so if you click on a link to another website, you should read their privacy policy.
Changes to our privacy policy
AMR.Solutions keeps its privacy policy under regular review and places any updates on this web page. This privacy policy was last updated on August 7, 2023.
How to contact us
If you have any questions about AMR.Solutions’s privacy policy, the data we hold on you, or you would like to exercise one of your data protection rights, please do not hesitate to contact us by email at privacy@amr.solutions.
Share
Now live: HERA’s call for rapid point-of-care susceptibility devices
Dear All, I wrote in the 19 Feb 2025 newsletter about HERA’s 13m EUR call for rapid point-of-care susceptibility devices. The call is now live! Title: Development of a Rapid Point-of-care Antimicrobial Susceptibility Testing Diagnostic Medical Device (HADEA/2025/CPN/0006) Funding and Tenders portal link: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/2e5c607e-6e55-4268-b99a-730c5db350b7-CN “This call for tenders aims to speed up the development of an in
Updates: CARB-X TPPs; Independent Panel for Evidence for Action against AMR
Dear All, Two quick updates this evening. First, you will recall that CARB-X have announced their initial 2025 funding round (26 Feb 2025 newsletter), with a call for applications for funding of work on (i) small molecules for Gram-negative infection and (ii) diagnostics for typhoid. In support of these calls, TPPs (target product profiles) for both
Unexpected resistance: The tale of rifaximin and daptomycin
Dear All (and with thanks to Patricia Bradford for taking the lead on this newsletter): Today, this paper in Nature takes us on a trip to the land of unintended consequences: Turner, A.M., Li, L., Monk, I.R. et al. Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin. Nature 635, 969–977 (2024). https://doi.org/10.1038/s41586-024-08095-4. A wonkish summary is found below
CARB-X announces its 2025 funding round
Dear All, At BEAM’s AMR Conference in Basel, Team CARB-X have today announced their 2025 funding round. Key points: Two themes: (i) Direct-acting small molecule therapeutics for Gram-negatives (same as in 2024) and (ii) diagnostics for typhoid fever in low-resource settings. 23 Mar 2025 newsletter update: The TPPs for both themes have been released: Small